Cargando…

No more tears from surgical site infections in interventional pain management

As the field of interventional pain management (IPM) grows, the risk of surgical site infections (SSIs) is increasing. SSI is defined as an infection of the incision or organ/space that occurs within one month after operation or three months after implantation. It is also common to find patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Seungjin, Yoo, Yeong-Min, Kim, Kyung-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Pain Society 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812697/
https://www.ncbi.nlm.nih.gov/pubmed/36581597
http://dx.doi.org/10.3344/kjp.22397
_version_ 1784863785368944640
author Lim, Seungjin
Yoo, Yeong-Min
Kim, Kyung-Hoon
author_facet Lim, Seungjin
Yoo, Yeong-Min
Kim, Kyung-Hoon
author_sort Lim, Seungjin
collection PubMed
description As the field of interventional pain management (IPM) grows, the risk of surgical site infections (SSIs) is increasing. SSI is defined as an infection of the incision or organ/space that occurs within one month after operation or three months after implantation. It is also common to find patients with suspected infection in an outpatient clinic. The most frequent IPM procedures are performed in the spine. Even though primary pyogenic spondylodiscitis via hematogenous spread is the most common type among spinal infections, secondary spinal infections from direct inoculation should be monitored after IPM procedures. Various preventive guidelines for SSI have been published. Cefazolin, followed by vancomycin, is the most commonly used surgical antibiotic prophylaxis in IPM. Diagnosis of SSI is confirmed by purulent discharge, isolation of causative organisms, pain/tenderness, swelling, redness, or heat, or diagnosis by a surgeon or attending physician. Inflammatory markers include traditional (C-reactive protein, erythrocyte sedimentation rate, and white blood cell count) and novel (procalcitonin, serum amyloid A, and presepsin) markers. Empirical antibiotic therapy is defined as the initial administration of antibiotics within at least 24 hours prior to the results of blood culture and antibiotic susceptibility testing. Definitive antibiotic therapy is initiated based on the above culture and testing. Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria infections appears to be superior to monotherapy in mortality with the risk of increasing antibiotic resistance rates. The never-ending war between bacterial resistance and new antibiotics is continuing. This article reviews prevention, diagnosis, and treatment of infection in pain medicine.
format Online
Article
Text
id pubmed-9812697
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Pain Society
record_format MEDLINE/PubMed
spelling pubmed-98126972023-01-11 No more tears from surgical site infections in interventional pain management Lim, Seungjin Yoo, Yeong-Min Kim, Kyung-Hoon Korean J Pain Review Article As the field of interventional pain management (IPM) grows, the risk of surgical site infections (SSIs) is increasing. SSI is defined as an infection of the incision or organ/space that occurs within one month after operation or three months after implantation. It is also common to find patients with suspected infection in an outpatient clinic. The most frequent IPM procedures are performed in the spine. Even though primary pyogenic spondylodiscitis via hematogenous spread is the most common type among spinal infections, secondary spinal infections from direct inoculation should be monitored after IPM procedures. Various preventive guidelines for SSI have been published. Cefazolin, followed by vancomycin, is the most commonly used surgical antibiotic prophylaxis in IPM. Diagnosis of SSI is confirmed by purulent discharge, isolation of causative organisms, pain/tenderness, swelling, redness, or heat, or diagnosis by a surgeon or attending physician. Inflammatory markers include traditional (C-reactive protein, erythrocyte sedimentation rate, and white blood cell count) and novel (procalcitonin, serum amyloid A, and presepsin) markers. Empirical antibiotic therapy is defined as the initial administration of antibiotics within at least 24 hours prior to the results of blood culture and antibiotic susceptibility testing. Definitive antibiotic therapy is initiated based on the above culture and testing. Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria infections appears to be superior to monotherapy in mortality with the risk of increasing antibiotic resistance rates. The never-ending war between bacterial resistance and new antibiotics is continuing. This article reviews prevention, diagnosis, and treatment of infection in pain medicine. The Korean Pain Society 2023-01-01 2023-01-01 /pmc/articles/PMC9812697/ /pubmed/36581597 http://dx.doi.org/10.3344/kjp.22397 Text en © The Korean Pain Society, 2023 https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Lim, Seungjin
Yoo, Yeong-Min
Kim, Kyung-Hoon
No more tears from surgical site infections in interventional pain management
title No more tears from surgical site infections in interventional pain management
title_full No more tears from surgical site infections in interventional pain management
title_fullStr No more tears from surgical site infections in interventional pain management
title_full_unstemmed No more tears from surgical site infections in interventional pain management
title_short No more tears from surgical site infections in interventional pain management
title_sort no more tears from surgical site infections in interventional pain management
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812697/
https://www.ncbi.nlm.nih.gov/pubmed/36581597
http://dx.doi.org/10.3344/kjp.22397
work_keys_str_mv AT limseungjin nomoretearsfromsurgicalsiteinfectionsininterventionalpainmanagement
AT yooyeongmin nomoretearsfromsurgicalsiteinfectionsininterventionalpainmanagement
AT kimkyunghoon nomoretearsfromsurgicalsiteinfectionsininterventionalpainmanagement